These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 34595733)

  • 1. Clinical Trial Design for Disease-Modifying Therapies for Genetic Epilepsies.
    Brock DC; Demarest S; Benke TA
    Neurotherapeutics; 2021 Jul; 18(3):1445-1457. PubMed ID: 34595733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-epileptogenic clinical trial designs in epilepsy: issues and options.
    Schmidt D; Friedman D; Dichter MA
    Neurotherapeutics; 2014 Apr; 11(2):401-11. PubMed ID: 24420312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Channelopathies in epilepsy: an overview of clinical presentations, pathogenic mechanisms, and therapeutic insights.
    Ng AC; Chahine M; Scantlebury MH; Appendino JP
    J Neurol; 2024 Jun; 271(6):3063-3094. PubMed ID: 38607431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational Small Molecule Treatment for Genetic Epilepsies.
    Goldberg EM
    Neurotherapeutics; 2021 Jul; 18(3):1490-1499. PubMed ID: 34431030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dravet Syndrome: Novel Approaches for the Most Common Genetic Epilepsy.
    Isom LL; Knupp KG
    Neurotherapeutics; 2021 Jul; 18(3):1524-1534. PubMed ID: 34378168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modifying genetic epilepsies - Results from studies on tuberous sclerosis complex.
    Jozwiak S; Kotulska K; Wong M; Bebin M
    Neuropharmacology; 2020 Apr; 166():107908. PubMed ID: 31962286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural History Studies and Clinical Trial Readiness for Genetic Developmental and Epileptic Encephalopathies.
    Palmer EE; Howell K; Scheffer IE
    Neurotherapeutics; 2021 Jul; 18(3):1432-1444. PubMed ID: 34708325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precision therapy in the genetic epilepsies of childhood.
    Byrne S; Enright N; Delanty N
    Dev Med Child Neurol; 2021 Nov; 63(11):1276-1282. PubMed ID: 34089185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epilepsy: expert opinion on emerging drugs in phase 2/3 clinical trials.
    Pong AW; Ross J; Tyrlikova I; Giermek AJ; Kohli MP; Khan YA; Salgado RD; Klein P
    Expert Opin Emerg Drugs; 2022 Mar; 27(1):75-90. PubMed ID: 35341431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomics-Guided Precise Anti-Epileptic Drug Development.
    Delanty N; Cavalleri G
    Neurochem Res; 2017 Jul; 42(7):2084-2088. PubMed ID: 28608234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Discoveries Drive Molecular Analyses and Targeted Therapeutic Options in the Epilepsies.
    Dhindsa RS; Goldstein DB
    Curr Neurol Neurosci Rep; 2015 Oct; 15(10):70. PubMed ID: 26319171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proceedings of the 15th Antiepileptic Drug and Device Trials Meeting: State of the Science.
    Boada CM; French JA; Dumanis SB
    Epilepsy Behav; 2020 Oct; 111():107189. PubMed ID: 32563052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Designing clinical trials to assess antiepileptic drugs as monotherapy : difficulties and solutions.
    Perucca E
    CNS Drugs; 2008; 22(11):917-38. PubMed ID: 18840033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monogenic Epilepsies: Disease Mechanisms, Clinical Phenotypes, and Targeted Therapies.
    Guerrini R; Balestrini S; Wirrell EC; Walker MC
    Neurology; 2021 Oct; 97(17):817-831. PubMed ID: 34493617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiological Biomarkers in Genetic Epilepsies.
    Armstrong C; Marsh ED
    Neurotherapeutics; 2021 Jul; 18(3):1458-1467. PubMed ID: 34642905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epilepsy: key experimental therapeutics in early clinical development.
    Steriade C; French J; Devinsky O
    Expert Opin Investig Drugs; 2020 Apr; 29(4):373-383. PubMed ID: 32172604
    [No Abstract]   [Full Text] [Related]  

  • 17. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personalized medicine in genetic epilepsies - possibilities, challenges, and new frontiers.
    Helbig I; Ellis CA
    Neuropharmacology; 2020 Aug; 172():107970. PubMed ID: 32413583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of genetic and experimental studies on classification and therapy of the epilepsies.
    Avanzini G; Mantegazza M; Terragni B; Canafoglia L; Scalmani P; Franceschetti S
    Neurosci Lett; 2018 Feb; 667():17-26. PubMed ID: 28522348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgery for epilepsy.
    West S; Nolan SJ; Cotton J; Gandhi S; Weston J; Sudan A; Ramirez R; Newton R
    Cochrane Database Syst Rev; 2015 Jul; (7):CD010541. PubMed ID: 26130264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.